These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 8370085)

  • 21. Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule.
    Groning R; Berntgen M
    Pharmazie; 1996 May; 51(5):328-31. PubMed ID: 8710954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori.
    Jain SK; Jangdey MS
    Mol Pharm; 2009; 6(1):295-304. PubMed ID: 19093870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of new sustained-release floating microspheres.
    Ma N; Xu L; Wang Q; Zhang X; Zhang W; Li Y; Jin L; Li S
    Int J Pharm; 2008 Jun; 358(1-2):82-90. PubMed ID: 18407442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and in vitro evaluation of expandable gastroretentive dosage forms based on compressed collagen sponges.
    Gröning R; Cloer C; Müller RS
    Pharmazie; 2006 Jul; 61(7):608-12. PubMed ID: 16889068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon.
    Pinto JF
    Int J Pharm; 2010 Aug; 395(1-2):44-52. PubMed ID: 20546856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro and In Vivo Evaluation of Carbopol 71G NF-Based Mucoadhesive Minitablets as a Gastroretentive Dosage Form.
    Rump A; Tetyczka C; Littringer E; Kromrey ML; Bülow R; Roblegg E; Weitschies W; Grimm M
    Mol Pharm; 2023 Mar; 20(3):1624-1630. PubMed ID: 36705398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation development of gastroretentive tablets of lamivudine using the floating-bioadhesive potential of optimized polymer blends.
    Singh B; Garg B; Chaturvedi SC; Arora S; Mandsaurwale R; Kapil R; Singh B
    J Pharm Pharmacol; 2012 May; 64(5):654-69. PubMed ID: 22471361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
    Lehr CM
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal dynamics and pharmacology for the optimum design of controlled-release oral dosage forms.
    Read NW; Sugden K
    Crit Rev Ther Drug Carrier Syst; 1988; 4(3):221-63. PubMed ID: 3276406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Companion animal physiology and dosage form performance.
    Sutton SC
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1383-98. PubMed ID: 15191788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Floating microspheres as drug delivery system: newer approaches.
    Jain SK; Agrawal GP; Jain NK
    Curr Drug Deliv; 2008 Jul; 5(3):220-3. PubMed ID: 18673266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system.
    Bott C; Rudolph MW; Schneider AR; Schirrmacher S; Skalsky B; Petereit HU; Langguth P; Dressman JB; Stein J
    Aliment Pharmacol Ther; 2004 Aug; 20(3):347-53. PubMed ID: 15274672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin.
    Chavanpatil MD; Jain P; Chaudhari S; Shear R; Vavia PR
    Int J Pharm; 2006 Jun; 316(1-2):86-92. PubMed ID: 16567072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral pulsatile delivery: rationale and chronopharmaceutical formulations.
    Maroni A; Zema L; Del Curto MD; Loreti G; Gazzaniga A
    Int J Pharm; 2010 Oct; 398(1-2):1-8. PubMed ID: 20655998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the intragastric location of extended release tablets on food interactions.
    Weitschies W; Wedemeyer RS; Kosch O; Fach K; Nagel S; Söderlind E; Trahms L; Abrahamsson B; Mönnikes H
    J Control Release; 2005 Nov; 108(2-3):375-85. PubMed ID: 16213057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry.
    Corá LA; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Stelzer M; Miranda JR
    Eur J Pharm Sci; 2006 Jan; 27(1):1-8. PubMed ID: 16188432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and evaluation of dual-mode floating gastroretentive tablets containing itraconazole.
    Kim JY; Rhee YS; Park CW; Ha JM; Park ES
    Drug Deliv; 2014 Nov; 21(7):519-29. PubMed ID: 24245857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastroretentive delivery of rifampicin: in vitro mucoadhesion and in vivo gamma scintigraphy.
    Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
    Int J Pharm; 2011 Jun; 411(1-2):106-12. PubMed ID: 21458549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.